ProXara Biotechnology Ltd. operates as a biotechnology company.
ProXara Biotechnology Ltd. operates as a biotechnology company, whose mission is to be a world leader in the development of novel therapeutically-relevant cell-based high throughput screens for drug discovery using fluorescent protein methodologies combined with imaging technologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2002 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sulis Innovation | — | Seed |